Leukemia Clinical Trials in Baltimore

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Active, not recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +3 more
  • Birmingham, Alabama
  • +42 more
2022-03-22
Mar 22, 2022
P
Active, not recruiting
  • Leukemia
  • +2 more
  • inotuzumab ozogamicin-dose level 2
  • Inotuzumab ozogamicin-dose level 1
  • Los Angeles, California
  • +45 more
2022-03-09
Mar 9, 2022
C
Recruiting
  • Acute Lymphoblastic Leukemia
  • +13 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +68 more
2022-03-03
Mar 3, 2022
I
Recruiting
  • Leukemia
  • Birmingham, Alabama
  • +107 more
2022-02-22
Feb 22, 2022
S
Recruiting
  • Leukemia
  • +5 more
  • Bone Marrow Transplant (BMT)
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2022-02-14
Feb 14, 2022
H
Recruiting
  • Chronic Myelomonocytic Leukemia
  • Leukemia
  • Tampa, Florida
  • +4 more
2022-01-26
Jan 26, 2022
A
Active, not recruiting
  • Leukemia
  • Birmingham, Alabama
  • +175 more
2021-08-16
Aug 16, 2021
A
Active, not recruiting
  • Leukemia
  • +2 more
  • laboratory biomarker analysis
  • San Diego, California
  • +50 more
2021-08-16
Aug 16, 2021
A
Active, not recruiting
  • Leukemia
  • DNA analysis
  • +3 more
  • San Diego, California
  • +160 more
2021-07-19
Jul 19, 2021
S
Completed
  • Leukemia
  • Duarte, California
  • +19 more
2021-06-07
Jun 7, 2021
A
Active, not recruiting
  • Leukemia
  • DNA analysis
  • +7 more
  • Mountain View, California
  • +76 more
2020-10-08
Oct 8, 2020
M
Active, not recruiting
  • Leukemia
  • Azacitidine (AZA) Days 1 - 3
  • +3 more
  • Tampa, Florida
  • +5 more
2020-07-21
Jul 21, 2020
A
Terminated
  • Leukemia
  • rituximab
  • fludarabine phosphate
  • Anniston, Alabama
  • +386 more
2020-04-09
Apr 9, 2020
U
Completed
  • Leukemia
  • filgrastim
  • +10 more
  • Baltimore, Maryland
    Greenebaum Cancer Center at University of Maryland Medical Cente
2019-10-31
Oct 31, 2019
U
Completed
  • Leukemia
  • +3 more
  • daclizumab
  • +4 more
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
2019-10-31
Oct 31, 2019
U
Completed
  • Leukemia
  • Lymphoma
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
2019-10-15
Oct 15, 2019
U
Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • bevacizumab
  • +2 more
  • Atlanta, Georgia
  • +2 more
2019-10-15
Oct 15, 2019
U
Completed
  • Leukemia
  • +3 more
  • anti-thymocyte globulin
  • +5 more
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
2019-10-15
Oct 15, 2019
U
Completed
  • Anemia
  • +5 more
  • anti-thymocyte globulin
  • +6 more
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
2019-10-15
Oct 15, 2019
U
Completed
  • Leukemia
  • +3 more
  • filgrastim
  • +3 more
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
2019-10-15
Oct 15, 2019